Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Safety and Biological Activity of ATYR1940 in Patients With Limb Girdle or Facioscapulohumeral Muscular Dystrophies
Conditions: Limb-Girdle Muscular Dystrophies; Facioscapulohumeral Muscular DystrophyInterventions: Biological: ATYR1940; Biological: PlaceboSponsor: aTyr Pharma, Inc.Recruiting - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2015 Category: Research Source Type: clinical trials
